The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine
拉丁裔人群中产生的抗 SARS-CoV-2 IgG1 和 IgG3 抗体同种型对 Omicron 具有有限的中和能力，在接种 mRNA 辉瑞-BioNTech 疫苗多次后转变为 IgG4
期刊:Viruses-Basel
影响因子:3.8
doi:10.3390/v16020187
Ana M Espino, Albersy Armina-Rodriguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I Rodriguez Martinó, Paola López-Marte, Esther A Torres, Carlos A Sariol
